Alzheimer’s disease patients with raised serum levels of pro-inflammatory cytokines IL-1β and TNF-α are indeed at increased risk of subsequent cognitive decline.6 This evidence concerns the gene TNF and early-onset autosomal dominant Alzheimer disease.